- Research article
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Role of P27-P55 operon from Mycobacterium tuberculosis in the resistance to toxic compounds
© Bianco et al; licensee BioMed Central Ltd. 2011
Received: 21 September 2010
Accepted: 16 July 2011
Published: 16 July 2011
The P27-P55 (lprG-Rv1410c) operon is crucial for the survival of Mycobacterium tuberculosis, the causative agent of human tuberculosis, during infection in mice. P55 encodes an efflux pump that has been shown to provide Mycobacterium smegmatis and Mycobacterium bovis BCG with resistance to several drugs, while P27 encodes a mannosylated glycoprotein previously described as an antigen that modulates the immune response against mycobacteria. The objective of this study was to determine the individual contribution of the proteins encoded in the P27-P55 operon to the resistance to toxic compounds and to the cell wall integrity of M. tuberculosis.
In order to test the susceptibility of a mutant of M. tuberculosis H37Rv in the P27-P55 operon to malachite green, sodium dodecyl sulfate, ethidium bromide, and first-line antituberculosis drugs, this strain together with the wild type strain and a set of complemented strains were cultivated in the presence and in the absence of these drugs. In addition, the malachite green decolorization rate of each strain was obtained from decolorization curves of malachite green in PBS containing bacterial suspensions.
The mutant strain decolorized malachite green faster than the wild type strain and was hypersensitive to both malachite green and ethidium bromide, and more susceptible to the first-line antituberculosis drugs: isoniazid and ethambutol. The pump inhibitor reserpine reversed M. tuberculosis resistance to ethidium bromide. These results suggest that P27-P55 functions through an efflux-pump like mechanism. In addition, deletion of the P27-P55 operon made M. tuberculosis susceptible to sodium dodecyl sulfate, suggesting that the lack of both proteins causes alterations in the cell wall permeability of the bacterium. Importantly, both P27 and P55 are required to restore the wild type phenotypes in the mutant.
The results clearly indicate that P27 and P55 are functionally connected in processes that involve the preservation of the cell wall and the transport of toxic compounds away from the cells.
Infection by Mycobacterium tuberculosis is a major health problem worldwide . Pathogenic mycobacterial species show remarkable ability to survive in the diverse conditions encountered during the infection process . However, even after decades of investigation, the knowledge about the mycobacterial pathogenesis remains insufficient. The identification of the genes associated with the multiplication and survival of bacilli in the host has provided a framework to study M. tuberculosis virulence . However, little is still known about the role of the encoded products in the interaction between the host and the pathogen. Elucidating these functions is then the next main challenge in tuberculosis research.
We have previously demonstrated that P27-P55 (lprG-Rv1410c) operon  is crucial for the survival of M. tuberculosis during infection in mice . P55 encodes for the efflux pump, which has been shown to provide resistance to several drugs, likely through a process coupled to oxidative balance within the cell . Also, it has been demonstrated that over-expression of P55 from M. tuberculosis in M. smegmatis confers resistance to several compounds by an efflux pumping activity . P27, on the other hand, encodes a lipoprotein previously described as an antigen in the M. tuberculosis complex  and, as many other mycobacterial lipoproteins, P27 is a mannosylated glycoprotein .
Although several publications have characterized the proteins encoded in the P27-P55 operon [4–14], the mechanism by which this operon contributes to the virulence of M. tuberculosis is still unclear. The finding that P27 causes an adverse effect when used as a protein-based vaccine , together with the fact that this glycolipoprotein inhibits MHC-II Ag processing, suggests that P27 acts modulating the immune response against mycobacteria (as an evasion mechanism) in favour of bacterial persistence .
Increasing evidence indicates that mycobacterial lipoproteins are involved in cell wall integrity either maintaining cell wall permeability  or participating in cell wall synthesis with specific functions . Recently, it has been shown that P27 acts in cooperation with P55 to transport ethidium bromide in M. smegmatis , indicating that P27 is necessary for P55-mediated transport across the cell membrane. Moreover, it has been recently proposed that in mycobacteria, P27 functions as a carrier of glycolipids during their trafficking and delivery to the mycobacterial cell wall .
In order to gain more insight into the function of the P27-P55 operon, in the present work, we studied the contribution of both P27 and P55 on the resistance to toxic compounds as well as on the cell wall integrity of M. tuberculosis.
Bacterial strains and culture media
All cloning steps were performed in Escherichia coli DH5α. E. coli was grown either in Luria-Bertani (LB) broth or on LB agar. Mycobacterium strains were grown in Middlebrook 7H9 medium supplemented with 0.05% Tween 80, albumin 0.5%, dextrose 0.4%, and 0.5% glycerol, or Middlebrook 7H10 supplemented with albumin 0.5%, dextrose 0.4%, and 0.5% glycerol. When necessary, 50 μg/ml hygromycin, 20 μg/ml kanamycin or 20 μg/ml reserpine were added to the media. Electrocompetent cells of the previously obtained M. tuberculosis ΔP27 (MtΔP27) mutant  were prepared following the procedure described in . For culture supernatant protein preparations, strains were cultured in Sauton supplemented with 0.5% glycerol.
Construction of ΔP27 M. tuberculosiscomplemented strains
Complemented strains of the MtΔP27 mutant  expressing either P27 or P55 were generated in this study. The P27 gene under the control of the P27-P55 operon promoter was cloned into the pNBV1 vector . pNBV1 was also used as a backbone vector to clone the P55 gene under the hsp60 promoter. These plasmids together with plasmid ΔP27C, which express the P27-P55 operon under its own promoter in the pNBV1 backbone , were used to transform MtΔP27 by electroporation . The resulting complemented strains are referred to as MtΔP27::P27, MtΔP27::P55 and MtΔP27::P27-P55, respectively.
Ethidium bromide sensitivity assays
M. tuberculosis strains were grown in liquid medium in the presence of either 1 μg/ml or 0.5 μg/ml of ethidium bromide. When necessary, 20 μg/ml reserpine was added into de cultures. Bacterial growth was monitored by optical density (OD) and compared to growth in the absence of ethidium bromide.
Malachite green decolorization assay
The malachite decolorization assay was performed as described in Banaei et al. . Briefly, malachite green (final concentration of 0.1 mg/liter) was added to 4 ml of mid-log bacterial cultures resuspended in phosphate-buffered saline (PBS) to an OD of 0.5 at 600 nm. When necessary, 20 μg/ml reserpine was added into de cultures. Bacterial suspensions were immediately centrifuged and the absorbance at 620 nm was measured in the supernatants at 10-min intervals. Because of the photooxidation of malachite green, tubes were covered with foil and the experiments were performed under reduced light. The experiment was repeated three times. The decolorization rates were expressed as nanograms of dye decolorized every 10 min per ml of culture.
Malachite green and SDS sensitivity assays
Two methods were used to determine the susceptibilities of the M. tuberculosis strains to sodium dodecyl sulfate (SDS). Firstly, a disc assay was used to determine the inhibition of growth in the presence of SDS. Briefly, bacterial suspensions containing 107 cells were spread on Middlebrook 7H10 agar plates, and discs containing 10 μl of 10% SDS were placed in the middle of the plate. Halos were recorded after two weeks at 37°C.
Secondly, the method described by Banaei et al.  was used to determine the loss of bacterial viability in the presence of a high concentration of SDS. Briefly, bacterial cultures grown to mid-log phase were diluted with growth medium to an OD of 0.05 at a wavelength of 600 nm and incubated with SDS 0.05% in duplicate. At 1 and 4 h, bacterial CFU were counted on Middlebrook 7H10 agar plates.
The malachite green sensitivity assay was performed as follows: bacterial suspensions with 106 cells were plated on Middlebrook 7H10 agar with or without 1 mg/liter of malachite green. Plates were incubated at 37°C in the dark and CFUs were counted after 21 days in plates without malachite green and after 40 days in plates containing malachite green.
Protein preparations, SDS-PAGE and Western blots
Subcellular fractions of Mycobacterium strains were obtained as previously described . Proteins were separated in SDS-PAGE and transferred to nitrocellulose filters. Western blot assays were performed as previously described  with the antibody anti-P27 Mab antibody (1:500). Alkaline phosphatase-conjugated anti-mouse immunoglobulin G (1:10000/Sigma-Aldrich) was used as secondary antibody.
First-line drug susceptibility testing (DST) by the colorimetric microplate-based method
To determine the minimal inhibitory concentration (MIC) of anti-tuberculosis drugs, a non commercial, microplate colorimetric-based method with resazurin (REMA) was used as a general indicator of cellular growth and viability, following a previously described method [20–22]. Briefly, a 96 wells, microtiter, flat bottom plate was used to perform DST to isoniazid, rifampicin and ethambutol. When necessary, 20 μg/ml reserpine was added into de cultures. Serial twofold dilutions of the drugs were performed and wells were left free of drugs to be used as growth controls. Wells were inoculated with 100 μl of 1:25 from a bacterial suspension with turbidity comparable to 1.0 MacFarland standard (original bacterial suspension). Plates were incubated for 5 days at 37°C at normal atmosphere. After the incubation period, 0.02% of resazurin was added to the wells and incubated for 24 h. The MIC for each particular drug was considered as the lowest concentration showing less change of colour than the growth controls.
The data were analyzed with Microsoft Excel statistical software using Student t test. p values <0.05 were considered statistically significant.
P27 localizes in the cell wall, cell membrane and culture supernatant
Sensitivity of ΔP27 mutant to malachite green
Rates of malachite green decolorization by M.tuberculosis ΔP27 strains
Decolorization rate§ +/- SD
Reserpine 20 μg/ml
The lack of P27 and P55 alters the cell wall permeability of M. tuberculosis
Susceptibility of M.tuberculosis ΔP27 strains to SDS
Inhibition zone (cm) §
3.75 (0.354) *
3.44 (0.134) *
3.05 (0.071) *
Sensitivity to isoniazid, ethambutol and ethidium bromide is increased in the ΔP27 mutant
Antimicrobial susceptibilities of M.tuberculosis ΔP27 strains
MIC (mg/liter) for M. tuberculosis strain*
The increased sensitivity to membrane-perturbing compounds, such as SDS, observed in the mutant MtΔP27 is in agreement with a recent report demonstrating that P27 has a role in M. tuberculosis cell wall integrity by binding to glycolipids . Other lipoproteins have also been demonstrated to have function related with cell wall of mycobacteria. Such is the example of LppX, a lipoprotein required for the translocation of phthiocerol dimycocerosates (DIM) to the outer membrane of M. tuberculosis . Here we found evidences suggesting that P55 is also required to maintain the cell wall impermeability of M. tuberculosis, which is consistent with its cell membrane localization . Although we have previously demonstrated that P27 localizes in the cell membrane fraction of M. bovis  here we showed that P27 is secreted to the culture supernatant of M. tuberculosis. However, a considerable amount of the protein was also detected in the mycobacterial cell wall, which is consistent with the proposed role of P27 in the transport of glycolipids such as lipomannans and lipoarabinomannans . Therefore, the localization of P27 in both culture supernatant and cell wall fractions suggests that the alteration of the cell wall integrity detected in the mutant may be due not only to the mislocalization of P27 in the cell wall but also to the lack of some specific function exerted by the secreted P27. Regarding to this last aspect, the structure of P27 from M. tuberculosis has been very recently defined and a role of P27 in the binding to mycobacterial glycolipids that are TLR2 agonists has been proposed . In agreement with the hypothesis that lipoproteins participate in the cell wall integrity, Banaei et al  found that the lack of LspA expression in M. tuberculosis causes higher susceptibility to malachite green and higher decolorization of this compound in the presence of the bacterium. These authors proposed that defects in cell wall permeability are responsible for the hypersensitivity of the lspA mutant to malachite green. We found that in the absence of P27-P55 expression, M. tuberculosis is extremely sensitive to malachite green and that the mutant decolorized malachite green faster than the wild type. The expression of P55 alone, but not of P27, in the mutant strain partially restored the wild type level of resistance to malachite green, supporting the idea that P55, through an efflux system is mainly involved in this phenomenon. Unfortunately, the addition of reserpine to strain cultures blocked the decolorization process, thus not allowing us to assess the effect of this drug in the efflux pump activity encoded in the P27-P55 operon.
The higher susceptibility to isoniazid and ethambutol of the MtΔP27 mutant is in agreement with a previous publication in which an increased expression of P55 was detected in the presence of isoniazid in a multidrug-resistant M. tuberculosis strain . Moreover, the involvement of P55 in the mechanism of antibiotic resistance has been demonstrated in Mycobacterium bovis BCG . Based on these results, which demonstrate that a P55-knockout M. bovis BCG strain is more susceptible to rifampicin, ethambutol and other drugs, Ramón-García et al. proposed that P55 plays an essential role of the efflux pump in detoxification processes coupled to oxidative balance within the bacterium. Consistently with that, here we found that both P27 and P55 provide M. tuberculosis with resistance to ethambutol; however, the susceptibility of M. tuberculosis to rifampicin was unchanged in the MtΔP27 mutant, suggesting that the intrinsic mechanism of antibiotic resistance is determined by the genetic background of the bacterial species.
The high susceptibility of MtΔP27 to ethidium bromide also supports a role of P27 and P55 in efflux transport. Farrow and Rubin have demonstrated that P55 mediates the transport of ethidium bromide outside M. smegmatis and that P27 is required for this process . The finding that reserpine alters the intrinsic resistance of M. smegmatis  and M. tuberculosis (this study) to ethidium bromide indicates that the susceptibility observed in the MtΔP27 mutant is due to the lack of the efflux pump function rather than to an increase in cell wall permeability. This assumption is supported by the fact that the introduction of P55 into the MtΔP27 mutant showed partial resistance to ethidium bromide.
Our results showed here demonstrate that P27 and P55 are functionally connected in processes associated with cell wall function by contributing to both the impermeability of the cell wall and the transport of toxic compounds away from the cells. In this regard, it has been proposed that P55 plays a role in the detoxification systems linked to respiratory processes and maintenance of the redox balance within the cell . Ongoing research is aimed to find out the precise role of P27 in these processes.
We propose that the requirement of P27 and P55 for the replication and persistence of the bacterium during the host infection is based on two aspects: the physiological role of P27 and P55 in cell wall function and transport, which are relevant during the in vivo growth of M. tuberculosis, and the antigenic properties of P27 to exert immune evasion during persistent M. tuberculosis infection.
The present study was supported by NIH 1R01AI083084-01, SECyT grant PICT2324 and INTA grant AEBIO243512. FB and AAC are CONICET fellows.
We thank Luis Fernandez for the bibliography provided. We also thank Dr. Belisle (Colorado State University) for providing us with the monoclonal anti-LprG antibody.
- The Current Status of TB in the World. The Art & Science of Tuberculosis Vaccine Development. Edited by: Mohd Nor N, Acosta A, Sarmiento ME. 2011, Selangor Darul Ehsan: Oxford Fajar Sdn. Bhd, Chapter 2: 18-29. 2Google Scholar
- Kirschner DE, Young D, Flynn JL: Tuberculosis: global approaches to a global disease. Curr Opin Biotechnol. 2010, 21: 524-523. 10.1016/j.copbio.2010.06.002.View ArticlePubMedPubMed CentralGoogle Scholar
- Smith I: Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev. 2003, 16: 463-496. 10.1128/CMR.16.3.463-496.2003.View ArticlePubMedPubMed CentralGoogle Scholar
- Bigi F, Alito A, Romano MI, Zumarraga M, Caimi K, Cataldi A: The gene encoding P27 lipoprotein and a putative antibiotic-resistance gene form an operon in Mycobacterium tuberculosis and Mycobacterium bovis . Microbiology. 2000, 146: 1011-1018.View ArticlePubMedGoogle Scholar
- Bigi F, Gioffré A, Klepp L, Santangelo MP, Alito A, Caimi K, Meikle V, Zumárraga M, Taboga O, Romano MI, Cataldi A: The knockout of the lprG-Rv1410 operon produces strong attenuation of Mycobacterium tuberculosis. Microbes Infect. 2004, 6: 182-187. 10.1016/j.micinf.2003.10.010.View ArticlePubMedGoogle Scholar
- Ramón-García S, Martín C, Thompson CJ, Aínsa JA: Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth. Antimicrob Agents Chemother. 2009, 53: 3675-3682. 10.1128/AAC.00550-09.View ArticlePubMedPubMed CentralGoogle Scholar
- Silva PE, Bigi F, Santangelo MP, Romano MI, Martín C, Cataldi A, Aínsa JA: Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2001, 45: 800-804. 10.1128/AAC.45.3.800-804.2001.View ArticlePubMedPubMed CentralGoogle Scholar
- Bigi F, Espitia C, Alito A, Zumarraga M, Romano MI, Cravero S, Cataldi A: A novel 27 kDa lipoprotein antigen from Mycobacterium bovis. Microbiology. 1997, 143: 3599-35605. 10.1099/00221287-143-11-3599.View ArticlePubMedGoogle Scholar
- González-Zamorano M, Mendoza-Hernández G, Xolalpa W, Parada C, Vallecillo AJ, Bigi F, Espitia C: Mycobacterium tuberculosis glycoproteomics based on ConA-lectin affinity capture of mannosylated proteins. J Proteome Res. 2009, 8: 721-733. 10.1021/pr800756a.View ArticlePubMedGoogle Scholar
- Farrow MF, Rubin EJ: Function of a mycobacterial major facilitator superfamily pump requires a membrane-associated lipoprotein. J Bacteriol. 2008, 190: 1783-1791. 10.1128/JB.01046-07.View ArticlePubMedGoogle Scholar
- Drage MG, Tsai HC, Pecora ND, Cheng TY, Arida AR, Shukla S, Rojas RE, Seshadri C, Moody DB, Boom WH, Sacchettini JC, Harding CV: Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2. Nat Struct Mol Biol. 2010, 17: 1088-1095. 10.1038/nsmb.1869.View ArticlePubMedPubMed CentralGoogle Scholar
- Gehring AJ, Dobos KM, Belisle JT, Harding CV, Boom WH: Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J Immunol. 2004, 15: 2660-2668.View ArticleGoogle Scholar
- Drage MG, Pecora ND, Hise AG, Febbraio M, Silverstein RL, Golenbock DT, Boom WH, Harding CV: TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis. Cell Immunol. 2009, 258: 29-37. 10.1016/j.cellimm.2009.03.008.View ArticlePubMedPubMed CentralGoogle Scholar
- Carroll MV, Sim RB, Bigi F, Jäkel A, Antrobus R, Mitchell DA: Identification of four novel DC-SIGN ligands on Mycobacterium bovis BCG. Protein Cell. 2010, 1: 859-870. 10.1007/s13238-010-0101-3.View ArticlePubMedPubMed CentralGoogle Scholar
- Hovav AH, Mullerad J, Davidovitch L, Fishman Y, Bigi F, Cataldi A, Bercovier H: The Mycobacterium tuberculosis recombinant 27-kilodalton lipoprotein induces a strong Th1-type immune response deleterious to protection. Infect Immun. 2003, 71: 3146-3154. 10.1128/IAI.71.6.3146-3154.2003.View ArticlePubMedPubMed CentralGoogle Scholar
- Sieling PA, Hill PJ, Dobos KM, Brookman K, Kuhlman AM, Fabri M, Krutzik SR, Rea TH, Heaslip DG, Belisle JT, Modlin RL: Conserved mycobacterial lipoglycoproteins activate TLR2 but also require glycosylation for MHC class II-restricted T cell activation. J Immunol. 2008, 180: 5833-5842.View ArticlePubMedPubMed CentralGoogle Scholar
- Banaei N, Kincaid EZ, Lin SY, Desmond E, Jacobs WR, Ernst JD: Lipoprotein processing is essential for resistance of Mycobacterium tuberculosis to malachite green. Antimicrob Agents Chemother. 2009, 53: 3799-37802. 10.1128/AAC.00647-09.View ArticlePubMedPubMed CentralGoogle Scholar
- Sulzenbacher G, Canaan S, Bordat Y, Neyrolles O, Stadthagen G, Roig-Zamboni V, Rauzier J, Maurin D, Laval F, Daffé M, Cambillau C, Gicquel B, Bourne Y, Jackson M: LppX is a lipoprotein required for the translocation of phthiocerol dimycocerosates to the surface of Mycobacterium tuberculosis. EMBO J. 2006, 25: 1436-1444. 10.1038/sj.emboj.7601048.View ArticlePubMedPubMed CentralGoogle Scholar
- Howard NS, Gomez JE, Ko C, Bishai WR: Colour selection with a hygromycin-resistance-based Escherichia coli-mycobacterial shuttle vector. Gene. 1995, 166: 181-182. 10.1016/0378-1119(95)00597-X.View ArticlePubMedGoogle Scholar
- Martin A, Morcillo N, Lemus D, Montoro E, Telles MA, Simboli N, Pontino M, Porras T, León C, Velasco M, Chacon L, Barrera L, Ritacco V, Portaels F, Palomino JC: Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs. Int J Tuberc Lung Dis. 2005, 9: 901-906.PubMedGoogle Scholar
- Pontino MV, Di Giulio B, Fernandez C, Imperiale B, Bodon A, Morcillo N: Evaluation of a colorimetric micromethod for determining the minimal inhibitory concentration of antibiotics against Mycobacterium tuberculosis. Rev Arg Microbiol. 2006, 38: 145-151.Google Scholar
- Morcillo N, Imperiale B, Di Giulio B: Evaluation of MGI 960 and the colorimetric-based method for tuberculosis drug susceptibility testing. Int J Tuberc Lung Dis. 2010, 14: 1169-1175.PubMedGoogle Scholar
- Jones JJ, Falkinham JO: Decolorization of malachite green and crystal violet by waterborne pathogenic mycobacteria. Antimicrob Agents Chemother. 2003, 47: 2323-2326. 10.1128/AAC.47.7.2323-2326.2003.View ArticlePubMedPubMed CentralGoogle Scholar
- Piddock LJ, Ricci V: Accumulation of KRM-1648 by Mycobacterium aurum and Mycobacterium tuberculosis. J Antimicrob Chemother. 2000, 45: 681-684. 10.1093/jac/45.5.681.View ArticlePubMedGoogle Scholar
- Colangeli R, Helb D, Sridharan S, Sun J, Varma-Basil M, Hazbón MH, Harbacheuski R, Megjugorac NJ, Jacobs WR, Holzenburg A, Sacchettini JC, Alland D: The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol. Mol Microbiol. 2005, 55: 1829-1840. 10.1111/j.1365-2958.2005.04510.x.View ArticlePubMedGoogle Scholar
- Jiang X, Zhang W, Zhang Y, Gao F, Lu C, Zhang X, Wang H: Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR. Microb Drug Resist. 2008, 14: 7-11. 10.1089/mdr.2008.0772.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/11/195/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.